Hologic to Acquire Somatex for ~$64 M

 Hologic to Acquire Somatex for ~$64 M

Hologic to Acquire Somatex for ~$64 M

Shots:

  • Hologic acquired Somatex Medical Technologies for ~$64M. The acquisition of Somatex’s differentiated products will enable Hologic to strengthen & expand its breast marker portfolio
  • The acquisition allows the company to expand its biopsy portfolio with the improvement in the biopsy experience for their patients. The acquisition provides Hologic additional expertise and capabilities to continue to grow its breast health portfolio
  • Somatex specializes in the development & manufacturing of minimally invasive devices in the areas of tumor diagnostics, biopsy and interventional specialties and includes the Tumark family of tissue markers, which were distributed by Hologic in the US prior to the acquisition

Click here ­to­ read full press release/ article | Ref: Hologic | Image: Mass Device

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post